Compound Libraries – Small Molecule, Fragment & Virtual

Diverse and Target-focused Compound Collections to Fit Your Needs

Eurofins Discovery offers drug-like small molecule screening collections curated to fit your precise needs. Benefit from our extensive resources, with our entire collection consisting of over 720,000+ compounds available to advance your research. We can screen subsets of our vast compound collection or screen the entire library for your project.
 
The design principle in the creation of these libraries focused on drug-like compounds with an emphasis on diversity. In addition, smaller target-focused libraries are also available as well as a bespoke fragment library, all tailor-made by our computational & medicinal chemistry teams.
 

Eurofins Discovery Screening Collections

Eurofins Discovery Compound Libraries provide access to extensive tractable hit-like property resources, offering you freedom to operate on selected hits:
 

500,000+ PlatinumDiv+ Library

  • High chemical diversity space driven by AI/ comp chem guided library design
  • HTS hits with superior lead-like properties (low molecule weight, good predicted solubility & permeability, including the blood-brain barrier)
  • High quality starting points for hit-to-lead programs
    500,000+ PlatinumDiv+ Library
  • PlatinumDiv+ derived subsets:

    Predefined subsets with less than 2.7% overlap allowing you the flexibility to scale to your project’s needs. 50-500K

    ExploreDiv+

    • 80K+ compound library
    • Explore new chemical spaces
    • Recent & innovative scaffolds

    CNSDiv+

    • 45K+ subset
    • High percentage MPO score
    • Good predicted blood-brain barrier permeability

    GPCRDiv+

    • 50K+ subset
    • GPCR focus subset

    CoreDiv+

    • 45K+ Core set representative of PlatinumDiv+ library chemical space
    PlatinumDiv+ derived subsets

1500+ MKAppoved Library

  • Prestwick Library of FDA & EMA approved drugs
  • Annotated library for targets, therapeutic indications and drug repurposing

1500+ MKAppoved Library

220,000+ GPCRGenius Library

  • Designed library for GPCR targets
  • Annotated for GPCR families & classes

220,000+ GPCRGenius Library

2,000+ Fragment ProbeSet

  • Novel potential starting points, available for immediate screening
  • High 3D shape, non-planar character, covering novel chemical space

2,000+ Fragment ProbeSet

Eurofins Discovery Virtual Library

  • 27 billion+ compounds virtual chemical libraries
  • Patent searching on 100s of millions of compounds
  • Ability to generate new libraries in collaboration with clients (based on known chemistry and building blocks)
  • Combined ligand-based and structure-based virtual screening approach
Eurofins Discovery Virtual Library

Additional Solutions

  • Client library housing & screening
  • 3rd party library screening
Key Areas

Address challenging targets and new modalities through AI-driven and conventional innovative strategies, with agile platforms and a collaborative approach.

Two important and commonly used computational techniques in drug discovery to identify potential drug candidates are ligand-based and structure-based virtual screening.

Your organization may have a novel target, pathway, or phenotype of interest, or a new approach in a well-explored area—along with challenges in program implementation.

Our chemistry services drive preclinical success by combining synthetic, computational, medicinal, and analytical chemistry with biology, delivering optimized molecules through an integrated, data-driven approach. With labs located strategically in Spain, US & India, we provide flexible Chemistry services to accelerate your Drug Discovery program.

Innovative platforms, including High-throughput Spectral Shift, SPR, MST, TSA and SLS/DLS for screening and compound profiling.

The generic approach to target disease-causing proteins is through small molecules that bind to and inhibit the enzymatic activity of the protein.

Questions? Contact Us

You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.

Questions? Contact Us